Evidence map›Paper›PMID 34440754›Full record

ReviewCells2021

Does

Verena von Bülow, Jakob Lichtenberger, Christoph G Grevelding, Franco H Falcone, Elke Roeb, Martin Roderfeld

Abstract readReview
In one paragraph

Review in Cells, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed.

  1. Article
  2. Tropical medicine and infectious disease · 2026
    Article
  3. Plant-Derived Terpenes as Emerging Therapeutics Against Schistosomiasis.International journal of molecular sciences · 2026
    Review
  4. Article
  5. Implications of host sex on liver metabolism duringFrontiers in cellular and infection microbiology · 2026
    Review
  6. Article
  7. Review
  8. Review
  9. Article
  10. Article
  11. Review
  12. Article
  13. Review
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. The short-term impact ofProceedings. Biological sciences · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Verena von BülowDepartment of Gastroenterology, Justus Liebig University, 35392 Giessen, Germany.
Jakob LichtenbergerDepartment of Gastroenterology, Justus Liebig University, 35392 Giessen, Germany.
Christoph G GreveldingInstitute of Parasitology, BFS, Justus Liebig University, 35392 Giessen, Germany.ORCID 0000-0002-3144-2026
Franco H FalconeInstitute of Parasitology, BFS, Justus Liebig University, 35392 Giessen, Germany.
Elke RoebDepartment of Gastroenterology, Justus Liebig University, 35392 Giessen, Germany.ORCID 0000-0001-5739-5400
Martin RoderfeldDepartment of Gastroenterology, Justus Liebig University, 35392 Giessen, Germany.ORCID 0000-0002-3232-1277

Funding

Deutsche Forschungsgemeinschaft RO3714/4-1Deutsche Forschungsgemeinschaft RO957/10-1GILEAD support program Infectiology 2017
6 · The paper itself

Abstract

Schistosomiasis is one of the most prominent parasite-induced infectious diseases, causing tremendous medical and socioeconomic problems. Current studies have reported on the spread of endemic regions and the fear of development of resistance against praziquantel, the only effective drug available. Among the

Indexed as

CarcinogenesisAnimalsCarcinoma, HepatocellularCarcinoma, Squamous CellHumansLiver NeoplasmsSchistosoma mansoniSchistosomiasisTh2 CellsUrinary Bladder NeoplasmscancercarcinomaHCCschistosomiasisS. mansoni

Identifiers

PMID34440754
PMCPMC8393187

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.